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Summary 
Background: Analysis of plasma adrenocorticotropic hormone concentration [ACTH] aids diagnosis 
of pituitary pars intermedia dysfunction (PPID). Comparisons of validated chemiluminescent-
immunoassay (CI) and immunofluorescent (IF) assays are limited. 
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Objectives: To compare the results of [ACTH] analysis by CI and IF methods of samples collected in 
autumn and spring and assess cross-reactivity. 
Study design: Method comparison. 
Methods: Plasma from non-laminitic ponies was analysed concurrently using the IF and CI methods 
in autumn and the following spring. Diagnostic thresholds for the IF method were derived using ROC 
curves and Youden indices to correspond with CI thresholds. Assay specificity was assessed using 
commercially available ACTH fragments and degradation products of endogenous ACTH. 
Results: CI and IF methods yielded different results (p<0.001); mean differences (CI–IF), (95% 
confidence intervals): Autumn (n = 99) 38.6 (30.6-46.5) pg/ml, Spring (n = 88) 5.1 (3.9-6.3) pg/ml. 
The association between CI and IF results differed in autumn and spring, consistent with seasonally 
dependent cross-reactivity or interference. Good (κ = 0.66-0.74) agreement was obtained for binary 
interpretation in spring between IF and CI using thresholds of >24 pg/ml and >29 pg/ml respectively 
and in autumn between IF and CI using thresholds of >27 pg/ml and >47 pg/ml respectively or >33 
pg/ml and >77 pg/ml respectively. Of 88 ponies with both spring and autumn samples, 56 (64%) 
exceeded a published autumn CI threshold (>47 pg/ml), of which 39 (70%) were below the 
equivalent threshold (<29 pg/ml) the following spring without treatment. The CI assay showed 
substantial apparent increases in [ACTH] following addition of high concentrations of CLIP (ACTH 18-
39). Degradation of ACTH during storage affected the assays differently. 
Main limitations: Limited numbers of PPID cases were included. Immunoreactivity of commercially 
available peptides may differ from their endogenous equivalents. 
Conclusions: The methods yielded different absolute values but the agreement for binary 
classification was good. An altered pituitary secretome in autumn that affects apparent [ACTH] 
values seems likely.  
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Introduction 
Equine pituitary pars intermedia dysfunction (PPID) is a common disease of older horses and ponies 
[1]. Plasma concentrations of the pro-opiomelanocortin (POMC) derived peptide 
adrenocorticotrophic hormone [ACTH] are often measured to aid diagnosis [1]. Seasonally adjusted 
reference ranges are recommended due to a physiological increase in pituitary hormone output in 
autumn [1].  In a large study in the United Kingdom, basal plasma [ACTH] >29 pg/ml in non-autumn 
months and >47 pg/ml in the autumn, measured using a chemiluminescent immunoassay (CI) [2], 
were consistent with a diagnosis of PPID [3]. Alternative diagnostic thresholds using the same 
method  have been derived from other populations, including >77 pg/ml in autumn months in 
Australia [4]. A ‘grey zone’ of 19-40 pg/ml in non-autumn months has been proposed,  within which 
results may be considered equivocal and re-testing at a later date or alternative tests may be 
indicated [5]. Recent discussion suggests the thresholds for diagnosis and the extent of 
‘grey/equivocal zones’ warrant further review[6]. 
In addition to the CI method, an automated ACTH immunofluorescence assay (IF) has recently been 
validated in the horse [7]. A previous study [7] to compare [ACTH] measured by the CI and IF 
methods concluded that correlation between the methods was good but with significant bias. 
Seasonal effects were not analysed and the study included only a small number (n = 4) of samples 
with very high measured ACTH concentrations (>100 pg/ml by the CI method).  
ACTH is a 39 amino-acid fragment of pro-opiomelanocortin (POMC) [1]. The manufacturers of the CI 
immunoassay report 13-15% cross reactivity with the C-terminal fragment of ACTH (ACTH 18-39) [8]  
known as corticotropin-like intermediate lobe peptide (CLIP). It is unknown whether this cross 
reactivity is clinically relevant in vivo in equine samples. No CI cross reactivity is reported to α-MSH 
(ACTH 1-17), or β-cell troponin (ACTH 22-39). No cross reactivity is reported by the manufacturers of 
the IF assay.  
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The study had 3 aims, namely 
1) In a cohort of ponies with no known history of laminitis, to compare the results of [ACTH] 
analysis by CI and IF methods in samples collected in the spring and autumn and to 
determine whether the two different methods provide equivalent categorical interpretation 
(PPID positive or negative at each time) when published diagnostic thresholds are used. 
2) In the same cohort, to determine whether the results of [ACTH] analysis were within a 
published (seasonally adjusted) reference range for the CI analyser [3] when tested in the 
same animals in the spring and the autumn.   
3) To assess the cross-reactivity of both assays using synthetic human ACTH fragments and by 
assessing the effect of delayed plasma analysis. 
 
Methods 
Ethical approval for the study was obtained from the Royal Veterinary College Ethics and Welfare 
Committee and the study was conducted under a UK Home Office licence (PPL 70/8195).   
Population study 
Subjects 
A subset of ponies from a larger on-going cohort study were included. Briefly, pony owners were 
recruited through internet searches and equestrian societies to obtain contact details for owners of 
groups of ponies kept within the county of Kent or within a 25-mile radius of the postcode ME18 
5GS. Pony owners were invited to participate in a cohort study investigating laminitis risk factors. 
Owners that were willing to participate were included if they expected to have at least 5 eligible 
ponies. Ponies were eligible for inclusion if they were ≤148 cm (149 cm with shoes), ≥5 years old and 
had no known history of laminitis. Ponies that were known to be pregnant, were receiving treatment 
for PPID or were clinically unwell at the time of examination were excluded from the cohort. The 
first 100 ponies to be recruited for the main cohort were eligible for inclusion in the study. 
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Data collection 
Each pony was visited during the autumn (September or October 2015) and then again in the 
following spring (March or April 2016). On each occasion, blood was collected for analysis of [ACTH]. 
Clinical signs of PPID noted by the owner or evident on veterinary examination were recorded in 
spring 2016. Specifically, the presence of hypertrichosis, a ‘pot belly’ or bulging supraorbital fat pads 
were assessed subjectively on veterinary examination. Owners were asked if each pony had suffered 
from laminitis or shown any of the following signs: lethargy or lack of energy, muscle wastage, 
supraorbital fat (fat bulging around the eyes), drinking or urinating excessively, long abnormal coat 
or delayed winter coat shedding, repeated infections. In spring 2016, the veterinary surgeon 
performing the examinations and the pony owners were blinded to the results of the ACTH analysis 
from autumn 2015 other than in one case that was unblinded for welfare reasons.  
 
Blood collection and ACTH analysis 
Blood was collected from the jugular vein into EDTA plastic vacutainersa. Whole blood was 
immediately chilled on ice packs to 4-10°C until it was separated by centrifugation (10 min at 2000 x 
g) the same day. Following centrifugation, plasma was aliquoted and stored at -20°C in the short 
term (up to 6 days) prior to longer term storage at -80°C. Samples were anonymised prior to analysis 
within 3-6 months. 
Plasma was thawed on the day of analysis. Samples were separated into 2 aliquots and analysed 
concurrently using two different automated analysers, a chemiluminescent immunoassay (ACTH 
Immulite 1000b (CI) and an immunofluorescent immunoassay (ST AIA ACTHc) (IF). The CI assay is a 
solid phase, 2-site sequential chemiluminescent immunometric assay that uses mouse monoclonal 
and rabbit polyclonal anti-human ACTH. The IF assay is a 2-site immunoenzymometric assay which 
uses 2 types of polyclonal goat anti-human ACTH antibodies [7]. Analysis and quality controls were 
performed according to manufacturers’ instructions. Any samples with significant haemolysis were 
excluded from analysis. 
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Cross reactivity/interference 
Cross reactivity to or interference by commercially available ACTH fragments was assessed using two 
pools of residual plasma from animals in the main cohort (samples taken in autumn 2016 and spring 
2017). The plasma samples had been thawed and analysed previously then stored at -20°C for up to 
6 months. The peptides α-MSH (ACTH 1-17)d, CLIP (ACTH 18-39)d and β-cell troponin (ACTH 22-39)d 
were obtained from a commercial supplier and had identical amino acid sequences to the human 
ACTH fragments. Each peptide was reconstituted with distilled water in borosilicate glass tubesd and 
serially diluted to produce working concentrations. Small volumes of synthetic peptide were added 
(spiked) to the pools of spring and autumn plasma to achieve peptide concentrations from 0-32000 
pg/ml. Each spiked sample was analysed concurrently using the IF and CI methods. 
 
Cross reactivity/interference from the natural degradation products of endogenous ACTH was 
assessed by analysing aliquots of plasma that had been stored at room temperature for 24, 48, 72 
and 96 hours to allow partial degradation of ACTH. Residual plasma from 10 clinical cases assessed 
for PPID by Bell Equine Veterinary Clinic were used, sample handling and temporary storage 
complied with clinical recommendations [13]. An aliquot of each sample was analysed concurrently 
using the IF and CI analysers on day 0 (for diagnostic purposes) and every 24 hours (days 1-4) until 
96 hours had elapsed. 
 
Data Analysis 
Clinical signs were reported as descriptive data. When the number of animals in each group was 
sufficiently large, associations between clinical signs and [ACTH] by each method were tested using 
Mann-Whitney U tests. Associations were considered significant if p<0.05 (a Bonferroni correction 
was applied for multiple comparisons).  
To determine whether there was an absolute difference between the results obtained using the CI 
and IF analysers the sample means for each method (from concurrent analysis) were compared by 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
paired sample t tests in the spring and autumn separately. The relationship between plasma ACTH 
concentrations as measured by the different methods were examined by scatter plots of the autumn 
and spring results. Linear regression was performed to examine the relationship between results 
generated using the two methods. Regression coefficients for spring and autumn were compared 
with an F test. The normality of the distributions of the differences between paired values and the 
residuals of linear regression were assessed using histograms. Percentage difference Bland-Altman 
plots [9] were created to show the limits of agreement between the methods in spring and autumn. 
   
To determine whether equivalent categorical agreement could be obtained using the different 
methods, spring and autumn thresholds were derived for the IF analyser to correspond to the 
published thresholds of >29 pg/ml and >47 pg/ml using the CI in the spring and autumn respectively 
[3]. Thresholds were also derived to correspond to an alternative autumn CI threshold derived by 
McGowan et al. (>77 pg/ml) [4] and to the upper and lower limits for equivocal results to correspond 
with the suggested ‘grey zone’ for the CI analyser (19-40 pg/ml) in non-autumnal months [5]. 
Thresholds for the IF were derived by generating ROC curves [10] for each CI threshold and 
calculating the whole number threshold with the highest Youden index [11]. To describe the 
agreement between the IF and CI methods if these thresholds were applied to IF results, Kappa 
statistics were calculated for a binary interpretation of [ACTH]. Weighted kappa (with linear weights 
for the disagreements) was calculated for the ordinal interpretation of results when the ‘grey zone’ 
for equivocal results was included [12]. Kappa values of >0.81 were considered to indicate very good 
agreement, 0.61-0.8 good, 0.41-0.6 moderate, 0.21-0.4 fair and <0.2 as poor [12].  
 
To determine whether the result of plasma ACTH analysis were within a published reference range 
[3] when tested in the same animals in the spring and the autumn, only CI results were analysed. 
Data from ponies that were unavailable in spring 2016 were excluded. Samples with [ACTH] >47 
pg/ml in autumn and >29 pg/ml in spring were considered positive for PPID.  
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Cross reactivity to synthetic peptides was not analysed statistically. For degradation of endogenous 
ACTH the percentage recovery of ACTH for each assay for days 1-4 was calculated as the percentage 
of the original (day 0) [ACTH] value for that assay. A mixed effects model was used to assess 
differences in [ACTH] recovery between assays. The dependent variable was [ACTH] percentage. 
Day, assay and their interaction were entered as fixed effects with day within subject as random 
effects (with AR1 covariance) using statistical softwaree. Recovery for each day was compared and 
differences were considered significant if p≤0.05, a Bonferroni correction was applied. 
 
All analyses were performed using statistical and graphical softwaree,f,g. 
 
Results 
Population study 
Blood samples were included from 99 ponies in autumn 2015 (one pony was excluded for 
behavioural reasons). There were 59 geldings and 40 mares with a mean age of 12.8 years (range 5-
27 years). Breed information was available for 85 ponies: 32 were described as Welsh or Welsh X, 13 
as Shetland, miniature Shetland or Shetland X (excluding Shetland x Welsh), 12 as Cob or Cob X, 6 as 
New Forest, 4 as Highland and 17 as other pony breeds or crosses. Eleven ponies were not used for 
any ridden exercise whereas all others had some ridden exercise.  
In spring 2016, 7 ponies had moved yards and were unavailable for re-sampling, one pony had 
developed laminitis and was therefore excluded from the cohort, a blood sample could not be 
obtained from one pony for behavioural reasons and two blood samples showed marked haemolysis 
and were excluded from analysis. Therefore, samples from 88 ponies were available for analysis in 
spring 2016. Complete data, including owner and veterinary assessment of clinical signs, were 
available for 86/88 ponies.  
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Box and whisker plots of [ACTH] as measured by each method and during the autumn and spring are 
shown in Figure 1. The distribution of the data was right skewed. Median, mean, (range) of the 
samples for each method were: autumn CI: 54.8, 74.0, (20.8 -328) pg/ml, spring CI: 20.5, 23.6, (11.2-
142.1) pg/ml, autumn IF: 27.6, 35.4 (10-142) pg/ml, spring IF: 16, 18.5 (4.3-59.3) pg/ml. 
There was a significant difference between the results obtained using the two methods in both 
autumn and spring. The mean differences (CI – IF), (95% confidence intervals and p values) were: 
autumn 38.6 (30.6-46.5 pg/ml p<0.001), spring 5.1 pg/ml (3.9-6.3 pg/ml, p<0.001). Bland-Altman 
analysis revealed a mean bias (limits of agreement) of 64.9% (17.1%-112.7%) in autumn and 28.8% (-
28%-85.6%) in spring (Supplementary Item 1). 
 
The associations between the values obtained using each assay are shown in Figure 2. Panel A shows 
all data. Some autumn samples had very high ACTH values, therefore to show the association 
between the analysers within a similar range of values panel B shows the associations between 
methods when [ACTH] values >100 pg/ml using the CI assay were excluded (16 autumn samples 
were excluded). Linear regression of all data indicated that in the autumn: IF (pg/ml) = 0.34 x CI + 
10.2 (r2 = 0.38) and in the spring: IF (pg/ml) = 0.86 x CI – 1.8 (r2 = 0.68). The relationship between the 
CI and IF assays differed significantly (p<0.001) between spring and autumn.  
 
Receiver operating characteristic (ROC) curve and Youden index calculations indicated that an IF 
spring diagnostic threshold of >24 pg/ml produced the greatest agreement with the previously 
recommended non-autumn CI threshold of >29 pg/ml. In the autumn, IF thresholds of >27 pg/ml and 
>33 pg/ml gave the best agreement with the previously recommended autumn CI thresholds of >47 
pg/ml and >77 pg/ml respectively. Using these IF thresholds, the agreement in binary classification 
was good. An IF ‘grey zone’ of 18-24 pg/ml for equivocal values gave greatest agreement with the 
non-autumn CI ‘grey zone’ (19-40 pg/ml). Agreement (weighted kappa) with an ordinal 
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interpretation (normal, grey zone or abnormal) was moderate. Thresholds and Kappa statistics are 
shown in Table 1. 
 
Seasonal variation in ACTH concentrations 
Both autumn and spring samples were available for analysis from 88 ponies. The results of 
classification of each pony as PPID positive or negative in the autumn and the following spring based 
on published thresholds  of 47 pg/ml and 29 pg/ml [3] using the CI assay are shown in Table 2. In 
autumn 2015 56/88 (64%) were classified as positive ([ACTH]> 47 pg/ml). In spring 2016 20/88 (23%) 
were classified as positive ([ACTH]> 29 pg/ml). Of the 56 ponies classified as positive in the autumn, 
39 (70%) were within the reference range the following spring. None of the ponies received 
pharmaceutical treatment for PPID during this period. 
 
Clinical signs of PPID 
Of the 88 samples used for analysis in spring 2016, complete clinical data were available for 86. 
Veterinary examination data was missing for one pony and owner information was missing from one 
pony. On veterinary examination, 3 (3%) ponies were considered to have hypertrichosis, 10 (12%) 
had bulging supraorbital fat pads and 18 (21%) were considered to have a pot belly. Owners 
reported a long abnormal coat or delayed winter coat shedding in two ponies (2%) (one of which 
was considered to have hypertrichosis on veterinary examination). Both lethargy and excessive 
drinking and urinating were reported in one pony (1%), muscle wastage was reported in one 
additional pony (1%). No owners considered their ponies to have recurrent infections or bulging 
supra-orbital fat pads. No signs consistent with PPID were present on veterinary examination or 
reported by owners in 59 (69%) of ponies. Insufficient clinical signs were reported by owners for 
statistical analysis statistical analysis was therefore only performed on signs that were noted on 
veterinary examination. Of the veterinary apparent signs, hypertrichosis was associated with [ACTH] 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
for both methods during both seasons (p<0.01-p = 0.012), there were no significant associations 
between bulging supra-orbital fat pads or a pot belly and [ACTH]. 
 
Cross reactivity study 
The results of addition of synthetic ACTH fragments are shown in Figure 3 and Supplementary Item 
2. One sample did not yield a result due to a sampling error (aspiration of a bubble). In summary, 
addition of CLIP at high concentrations substantially increased apparent [ACTH] using the CI assay 
but had no effect on the IF assay, although the percentage cross reactivity was low (1-2% at [CLIP] ≥ 
2000 pg/ml for the CI assay). At high concentrations α-MSH reduced apparent [ACTH] using the IF 
assay but had no apparent effect on the CI assay. High concentrations of β-cell troponin also reduced 
apparent [ACTH] using the IF assay and the CI assay at the very highest concentration (50 000 pg/ml) 
only. 
 
The results of analysis of endogenous ACTH during storage for up to 96 hours at room temperature 
are shown in Figure 4. There was insufficient remaining sample on day 4 for analysis of 3 samples.  
Mixed effect model analysis revealed that recovery of [ACTH] was significantly higher for the CI assay 
than the IF assays on days 3 and 4 (p = 0.032 and <0.01) consistent with endogenous ACTH 
degradation products cross reacting with the CI assay or interfering with the IF assay. 
 
Discussion 
The results of the current study are consistent with those of Irvine et al. [7] in which the results 
obtained with the IF assay were proportional to, but lower than, those obtained using the CI assay. 
In the current study, a different relationship was found between [ACTH] results generated by the 
two methods when measuring concentrations in samples collected from the same animals in the 
autumn compared with the spring.  A probable explanation for this finding is cross reactivity to or 
interference by a substance present in equine plasma at greater concentrations in the autumn than 
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the spring, such as other POMC derived peptides. Whilst both the CI and IF assays have previously 
undergone similar validation procedures in the horse [2,6], studies in the horse have not fully 
investigated cross reactivity of either assay to other POMC derived peptides, nor compared assay 
results with gold standard techniques such as liquid chromatography-mass spectrometry (LC-MS).   
 
The occurrence of cross reactivity or interference was firstly investigated by the addition of 
commercially available synthetic ACTH fragments to equine plasma samples. Cross-reactivity or 
interference was demonstrated with both assays. The most marked effect was of CLIP on the CI 
assay; however, for both assays these effects only occurred at concentrations of the three ACTH 
fragments that are likely to be supraphysiological. The calculated cross reactivity of 1-2% to CLIP in 
equine plasma was surprisingly low given the manufacturer’s report of 13-15% cross reactivity in 
human plasma [8]. The cross reactivity or interference was secondarily investigated by determining 
the difference in ACTH recovery following room temperature storage during which degradation of 
the endogenous ACTH to fragments would occur. Recovery of [ACTH] was significantly higher for the 
CI assay than the IF assays on days 2-4, consistent with endogenous ACTH degradation products 
cross reacting with the CI assay or interfering with the IF assay. The true extent to which equine 
ACTH degrades under such conditions is unknown and it is not possible to determine which assay is 
more accurate for detection of intact ACTH. 
 
The apparent difference between the cross reactivity/interference seen with samples from normal 
ponies and the lack of cross reactivity seen with the synthetic commercially available ACTH 
fragments could reflect altered immunoreactivity of the synthetic fragments compared with their 
endogenous counterparts. Such differences could result from  sequence differences or post-
translational modification such as glycosylation, acetylation, amidation and phosphorylation [14]. 
Partial sequence data for the equine POMC gene indicate some differences from human sequences, 
particularly for CLIP [15]. The use of recombinant peptides based on the equine POMC sequence 
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may have yielded different results. Alternatively, other POMC fragments, not analysed in the current 
study, could be responsible for the cross-reactivity/interference that is apparent in vivo. Further 
studies are warranted to explore these possible explanations. 
 
Assuming cross-reactivity or interference occurred, the data in the current study indicate a seasonal 
effect on the concentration of the substance(s) responsible. Marked seasonal effects are described 
for the circulating concentrations of POMC derived peptides in the horse, in particular alpha-
melanocyte-stimulating-hormone (∝-MSH; POMC amino acids 1-13) [1,4,16] . The magnitude of 
autumnal increases in plasma  ∝-MSH concentrations typically exceed those of ACTH and in one 
study, there was a more marked autumnal increase in ponies (11 fold increase) when compared with 
horses (2-fold increase) [17]. The seasonal effects on plasma concentrations of CLIP and other POMC 
derived peptides are not well reported in the horse, however an increase of similar magnitude to ∝-
MSH would be expected for CLIP. Further, in PPID the concentrations of a range of POMC derived 
peptides may greatly exceed the increase in [ACTH] [18]. The equine pituitary secretome, and its 
seasonal variation in health and disease, is complex and assessment of plasma [ACTH] alone is likely 
to be a crude indicator of pituitary secretory activity. The current study suggests that unidentified 
changes in the pituitary secretome of clinically healthy ponies affects the performance of ACTH 
assays. It is unclear which assay has greatest diagnostic accuracy for PPID and further validation 
work of both assays in a population with a higher proportion of animals with clinical signs suggestive 
of PPID is required. 
 
For clinicians that wish to use the IF assay, applying 24 pg/ml and 27 pg/ml as the upper limit of the 
reference range in the spring and autumn respectively to the ponies in this cohort produced good 
agreement with a published reference range for the CI analyser in the UK. Agreement for the ordinal 
classification of results as normal, equivocal or abnormal was weaker than for binary classification, 
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but still considered to be moderate. The improved recovery of ACTH when using the CI assay may 
also be relevant for clinicians if sample analysis is delayed. The high levels of ACTH recovery are 
consistent with other reports using the CI assay in the horse in which recovery is higher than would 
be expected in other species [2,19] such findings could be due to cross-reactivity of ACTH 
breakdown products.  
 
A high proportion of ponies (64%) exceeded a published reference range (>47 pg/ml) in the autumn 
using the CI assay despite the relatively low prevalence of clinical signs, including an absence of 
laminitis, reported by owners or evident on veterinary examination. The majority (70%) of these 
ponies returned to within the seasonally adjusted reference range in the spring without receiving 
any treatment. It is unclear whether these findings indicate a very high burden of subclinical disease 
that is only revealed in the autumn, or an inappropriately low autumn diagnostic threshold. Early 
clinical signs of PPID may be subtle [13] and animals with early disease may have been overlooked. 
However many of the owners in the current study were very experienced and would be expected to 
be adept at distinguishing between normal and abnormal ponies. A very high diagnostic accuracy has 
been reported for diagnosis of PPID based on a higher basal [ACTH] threshold (>77 pg/ml) during the 
autumn [4], however autumn basal ACTH samples were only available from 4 cases that were 
considered PPID positive based on clinical signs. It Is also suggested that ponies may have a greater 
seasonal increase in [ACTH] than horses [13] and a higher diagnostic threshold may therefore apply. 
Clinicians should interpret the results of basal ACTH testing with caution and with reference to 
clinical signs, larger equivocal diagnostic ranges may be required [6]. For horses that are diagnosed 
with PPID during the autumn, begin pergolide treatment and are then re-tested the following spring 
clinicians should be cautious before attributing a return of ACTH to reference range to pergolide 
treatment. Additional prospective clinical studies are warranted to determine the most appropriate 
diagnostic thresholds for ponies and their relationship with the presence of and development of 
clinical signs of PPID. It is currently unclear whether the IF or CI assay will have greater diagnostic 
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accuracy or whether specificity for ACTH is required for diagnosis of PPID. Cross reactivity to other 
POMC derived peptides produced by a dysfunctional pars intermedia could potentially result in 
improved diagnostic accuracy. 
 
The current study had several limitations. Primarily, the true PPID status of the subjects was not 
determined. Insufficient numbers of ponies with definitive clinical signs were included in this largely 
healthy cohort and no histological testing or TRH stimulation tests were performed. The study 
therefore could not address whether either assay was superior to the other. Many clinical signs of 
PPID are non-specific and both veterinary and owner assessment of signs are highly subjective. The 
most biologically plausible explanation for the seasonally variable association between the assays 
was considered to be cross-reactivity/interference with unidentified POMC derived peptides in the 
autumn. A more rigorous analysis of this hypothesis would have required more sophisticated 
analysis of the autumnal pituitary secretome such as an HPLC-MS based approach and further work 
to address this question is warranted. 
 
In conclusion, the CI and IF assays cannot be used interchangeably but good binary and moderate 
ordinal interpretation can be obtained using assay specific and season specific diagnostic thresholds. 
The seasonal difference in the association between the assays suggests assay cross 
reactivity/interference to an altered autumnal pituitary secretome; however, the identity of the 
cross-reacting or interfering substance remains unknown and requires further investigation. Finally, 
a large proportion (70%) of ponies whose [ACTH] was above currently recommended reference 
ranges in the autumn had [ACTH] concentrations within the reference range the following spring 
without receiving any treatment for PPID. 
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Figure legends: 
Fig 1: Box and whisker plots of ACTH concentrations measured with the CI or IF analysers in the 
Autumn or Spring. Whiskers indicate maximum and minimum values, box borders the first and third 
quartiles and the horizontal line within each box denotes the median value.  
 
Fig 2: Scatter plots of [ACTH] measured using the CI and IF methods. Panel A shows all data. Panel B 
only includes data points with ACTH <100 pg/ml (using the CI assay) to indicate the different 
seasonal relationship within a similar range of values. 
 
Fig 3: Apparent [ACTH] on addition of ACTH fragments. 
 
Fig 4: Percentage recovery of ACTH following storage at room temperature. Significant differences 
between recovery with each assay (p<0.05) are marked with asterisks. 
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Table 1: Commonly used chemiluminescent thresholds with corresponding values for the 
immunofluorescent and kappa statistics of agreement. 
Season Chemiluminescent  
threshold 
(pg/ml) 
Immunofluorescent  
threshold  
(pg/ml) 
Kappa 
(95% confidence 
intervals) 
Non-autumn >29 >24 0.74 (0.57-0.91) 
19-40 ‘grey zone’ 18-24 0.52 (0.38-0.65) 
Autumn >47 >27 0.66 (0.51-0.80) 
>77 >33 0.69 (0.54-0.84) 
 
 
 
Table 2: ACTH results using the CI assay with reference to commonly used diagnostic thresholds for 
the same ponies when tested in autumn 2015 and spring 2016. 
Autumn 15 Spring 16 
 
High (>47 pg/ml) 
N = 56 
High (>29 pg/ml) 
N = 17 
Normal (≤29 pg/ml) 
N = 39 
 
Normal (≤47 pg/ml) 
N = 32 
High (>29 pg/ml) 
N = 3 
Normal (≤29 pg/ml) 
N = 29 
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Supplementary information items 
 
Supplementary Item 1: Bland-Altman plot. 
 
Supplementary Item 2: Apparent [ACTH] following addition of synthetic peptides to pooled plasma. 
 
 
Table 1: Commonly used chemiluminescent thresholds with corresponding values for the 
immunofluorescent and kappa statistics of agreement. 
Season Chemiluminescent  
threshold 
(pg/ml) 
Immunofluorescent  
threshold  
(pg/ml) 
Kappa 
(95% confidence 
intervals) 
Non-autumn >29 >24 0.74 (0.57-0.91) 
19-40 ‘grey zone’ 18-24 0.52 (0.38-0.65) 
Autumn >47 >27 0.66 (0.51-0.80) 
>77 >33 0.69 (0.54-0.84) 
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Table 2: ACTH results using the CI assay with reference to commonly used diagnostic thresholds 
for the same ponies when tested in autumn 2015 and spring 2016. 
 
Autumn 15 Spring 16 
 
High (>47pg/ml) 
N=56 
High (>29pg/ml) 
N=17 
Normal (≤29pg/ml) 
N=39 
 
Normal (≤47pg/ml) 
N=32 
High (>29pg/ml) 
N=3 
Normal (≤29pg/ml) 
N=29 
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